Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Leukemia, Myeloid, Acute × Transplantation × Clear all

Phase

Status

Completed 11 Terminated 5 Active not recruiting 2 Withdrawn 1 Unknown 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1

Interventions

Cytarabine 57 Decitabine 33 Azacitidine 29 Idarubicin 22 venetoclax 20 fludarabine 17 Cyclophosphamide 17 Granulocyte Colony-Stimulating Factor 15 Daunorubicin 12 Mitoxantrone 9 Busulfan 9 Etoposide 8 Cladribine 8 Aclarubicin 8 Homoharringtonine 7 Filgrastim 7 fludarabine phosphate 6 Peripheral Blood Stem Cell Transplantation 6 Mycophenolic Acid 5 Cyclosporine 5 aclacinomycins 4 Tretinoin 4 Sorafenib 4 Radiotherapy 4 Polymerase Chain Reaction 4 Lenalidomide 4 Gemtuzumab 4 Clofarabine 4 Arsenic Trioxide 4 sargramostim 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00449319 2017-11-17

LAM99P

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡